You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 11, 2024

Details for Patent: 8,282,967

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 8,282,967 protect, and when does it expire?

Patent 8,282,967 protects ZELSUVMI and is included in one NDA.

This patent has thirteen patent family members in six countries.

Summary for Patent: 8,282,967

Title:	Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
Abstract:	The presently disclosed subject matter relates to nitric oxide-releasing particles for delivering nitric oxide, and their use in biomedical and pharmaceutical applications.
Inventor(s):	Schoenfisch Mark H., Shin Jae Ho, Stasko Nathan
Assignee:	The University of North Carolina at Chapel Hill
Application Number:	US13168597
Patent Claim Types: see list of patent claims

Drugs Protected by US Patent 8,282,967

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Lnhc	ZELSUVMI	berdazimer sodium	GEL;TOPICAL	217424-001	Jan 5, 2024		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial		Y			⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 8,282,967

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2006249323	⤷ Try a Trial
Canada	2606565	⤷ Try a Trial
Canada	2912259	⤷ Try a Trial
European Patent Office	1888510	⤷ Try a Trial
European Patent Office	2669269	⤷ Try a Trial
European Patent Office	3556401	⤷ Try a Trial
Spain	2731298	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.